Cite
APA Citation
Ali, R., Babad, J., Follenzi, A., Gebe, J. A., Brehm, M. A., Nepom, G. T., Shultz, L. D., Greiner, D. L., & DiLorenzo, T. P. (2016). genetically modified human CD4+ T cells can be evaluated in vivo without lethal graft‐versus‐host disease. Immunology, 148(4), 339–351. http://access.bl.uk/ark:/81055/vdc_100034811912.0x00005f